This is because TAMs can not only release chemotherapy resistance factors, making breast cancer cells insensitive to chemotherapy, but also exhibit increased release of VEGF under radiation exposure, thus reducing radiotherapy sensitivity46. The gene discussed is VEGFA; the disease is breast cancer.